Insight Briefs5 May 2026 The eCOA Iceberg: uncovering the hidden costs of software-only models SaaS eCOA looks cheaper on paper. This guide exposes five hidden costs that change the full-service vs. software-only...
Insight Briefs24 April 2026 The ePRO blueprint for pain trials: Optimizing data capture from protocol design to efficacy endpoints The 11-point electronic Numeric Rating Scale (eNRS) is now the preferred digital standard for BYOD pain trials, recommended...
Insight Briefs15 January 2026 The real-time monitoring dilemma Offline eCOA capability creates regulatory tension with EMA device-as-source requirements while eliminating real-time monitoring capabilities that drive 80-95%...
Insight Briefs25 November 2025 Is Your eCOA UAT Stuck in Time? Modern clinical trials increasingly rely on complex, time-sensitive logic within eCOA systems, such as narrow compliance windows and...
Insight Briefs18 November 2025 The End of the “PRO Tax”: Top 10 Commercial PROs & their cost-effective alternatives The clinical trial industry faces a "PRO Tax"—the high costs and operational delays associated with licensing and implementing...
Insight Briefs17 November 2025 The Silent Saboteurs: Why Rater Drift and Site Unpreparedness Cost CNS Trials More CNS trials fail not from technology limitations but organizational factors. Research reveals 55% of sites lack adequate eCOA...
Insight Briefs17 November 2025 Hospital-Based eCOA Implementation: Real Challenges in Infectious Disease Trials Hospital-based infectious disease trials face unique eCOA implementation challenges including IT security delays, staff turnover, and patient acuity...
Insight Briefs30 October 2025 Implications of Assessing Overall Survival in Oncology Studies The FDA’s August 2025 draft guidance reshapes oncology clinical trials by requiring pre-specified overall survival (OS) analysis in...
Insight Briefs27 October 2025 The Patient Experience Paradox: eCOA Strategy Overhaul Discover how the EMA’s new Patient Experience Data (PED) guidance and the EU HTA Regulation are reshaping evidence...
Insight Briefs14 August 2025 Navigating the eCOA Vendor Landscape: What Clinical Teams Really Need to Know The eCOA market reached $2.27 billion in 2025 with 16.1% projected growth, yet vendor selection remains critical for...
Insight Briefs7 August 2025 Optimizing eCOA in Oncology Trials: Patient-Focused Data Capture for Cancer Research Oncology leads clinical innovation with 7,747 trials registered through 2022, yet only 7% of cancer patients participate. This...